Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

Elevance Health (ELV ... Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Elevance Health, Inc. (ELV), with a market ... the past six months and 24.2% over the past 52 weeks. Nevertheless, Wall Street analysts remain strongly bullish on ELV’s prospects.

As Wall Street’s broader market averages continue ... No. 9: Bristol-Myers Squibb (BMY), +5.8% YTD. No. 8: Elevance Health (ELV), +7.2% YTD. No. 7: Altria Group (MO), +9.6% YTD.

Elevance Health, Inc. (ELV), with a market cap of $89.92 billion, is a leading health benefits company in the United States. Based in Indianapolis, Indiana, ELV offers a variety of health plans and ...

U.S. health benefits company Elevance Health, Inc. ELV appears undervalued. It is currently trading at 12.25X forward 12-month earnings, below its five-year median of 13.44X and the industry average ...

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

February 11, 2025 Wall Street ends higher on AI strength ... investor concerns with better-than-feared quarterly profit Elevance Health on Thursday posted a better-than-feared fourth-quarter ...

Rep. Jefferson Shreve recently purchased shares of Elevance Health valued between $15,001 and $50,000. The disclosure, filed on March 9, also revealed additional investments in major companies, ...

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Thursday. Several other ...